RAF1 and acute myeloid leukemia: In particular, in all AML cells, we identified high levels of H3K79me2 in RAF1 and BRAF genes, both encoding for Sorafenib-target kinases, indicating a possible mechanism by which Pinometostat could enhance Sorafenib cytotoxicity.